Content provided by the Catalog of Federal Domestic Assistance
93.838 Lung Diseases Research
NATIONAL INSTITUTES OF HEALTH, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service Act, Section 301, 422 and 487, as amended, Public Laws 78-410 and 99-158, 42 U.S.C. 241, 42 U.S.C. 285, and 42 U.S.C. 288, as amended; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564.
To use available knowledge and technology to solve specific disease problems of the lungs; to promote further studies on the structure and function of the lung; and to achieve improvement in the prevention and treatment of lung diseases. Small Business Innovation Research (SBIR) program: To expand and improve the SBIR program; to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. Small Business Technology Transfer (STTR) program: To stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.
TYPES OF ASSISTANCE:
USES AND USE RESTRICTIONS:
Grants may support salaries, equipment, supplies, travel, and patient hospitalization as required to perform the research effort. Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research. National Research Service Awards (NRSAs) are made directly to individuals for research training in specified biomedical shortage areas. Grants may be made to institutions to enable them to make NRSAs to individuals selected by them. Certain service and payback provisions apply to individuals upon termination of the award. SBIR Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants are for the continuation of the research initiated in Phase I and which are likely to result in commercial products or processes. Only Phase I awardees are eligible to apply for Phase II support. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential on Phase II application.
Applicant Eligibility: Any nonprofit organization engaged in biomedical research, as well as institutions or companies organized for profit, may apply for grants with the exception of NRSAs. An individual may apply for a NRSA or, in some cases, may qualify for a research grant if adequate facilities in which to perform the research are available. SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more than 500 employees). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which research is proposed and have no more that 500 employees) which "partner" with a research institution in cooperative research and development. At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Pre-application Coordination: Not applicable. This program is excluded from coverage under E.O. 12372.
Formula and Matching Requirements: This program has no statutory formula or matching requirements.
POST ASSISTANCE REQUIREMENTS:
Reports: Annual reports on progress and expenditures. Final reports are required within 120 days of termination. Reports are required after termination of National Research Service Awards to ascertain compliance with the service and payback provisions.
Account Identification: 75-0872-0-1-552.
In fiscal year 2001, 1,132 research grants and 97 National Research Service Awards were made. The estimates for fiscal year 2002 are 1,218 research grants and 97 National Research Service Awards. The estimates for fiscal year 2003 are 1,243 research grants and 97 National Research Service Awards. In fiscal year 2001, for new and competing renewal awards: 891 grant applications were received, and of these, 318 were awarded; 84 National Research Service Award applications were received, and of these, 30 were awarded. Small Business Innovation Research Awards: In fiscal year 2001, 21 Phase I awards and 8 Phase II awards were made.
REGULATIONS, GUIDELINES, AND LITERATURE:
42 CFR 52; 42 CFR 66; 45 CFR 74; 45 CFR 92; "NIH Guide for Grants and Contracts, and Supplements"; PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, (Rev.) April 1, 1994; Grants will be available under the authority of and administered in accordance with the PHS Grants Policy Statement and Federal regulations at 42 CFR 52 and 42 U.S.C. 241; Omnibus Solicitation of the Public Health Service for Small Business Innovation Research (SBIR) Grant and Cooperative Agreement Applications. Omnibus Solicitation of the National Institutes of Health for Small Business Technology Transfer (STTR) Grant Applications.
Regional or Local Office: Not applicable.
EXAMPLES OF FUNDED PROJECTS:
(1) An individual research grant to investigate basic mechanisms of primary pulmonary hypertension, a lethal disease that causes progressive obstruction of small pulmonary arteries. This grant has established a national registry of familial primary pulmonary hypertension that is providing the framework for linkage analysis and the molecular search for basic mechanisms of this disease. (2) A multi-project grant dealing with cellular and molecular mechanisms underlying acute and chronic asthma. The focus of this program is on the mechanisms causing asthma in humans. The work includes laboratory projects, animal research, and human studies. The work includes laboratory projects and animal research concentrated on the cellular pathways of the asthmatic inflammatory process, focused on the mast cell, a critical cell type in asthma. (3) A grant for a Specialized Center of Research (SCOR) in the Pathobiology of Fibrotic Lung Disease. The long term objective of this program is to further understanding of the pathogenesis and treatment of idiopathic interstitial pneumonias. The center hypothesis is: Local alterations in the elaboration of effector molecules or in the expression of receptors by inflammatory, epithelial, and mesenchymal cells create an alveolar microenvironment that favors the fibroproliferative response rather than normal repair. Such dysregulation determines susceptibility to and expression of fibrotic lung disease. 4) An Individual National Research Service Award to study the effect of temperature on the medullary respiratory network, which controls respiratory activity. Breathing is modulated as the result of change in the internal and external environment and the behavioral state of the human or animal. The research findings will be of importance by virtue of the epidemiological linkage between environmental hyperthermia and sudden infant death syndrome, and cardiorespiratory failure during heat exhaustion and stroke. The fellow will train under the guidance of an outstanding mentor with a strong record of training scientists, and will develop research skills in important areas of electrophysiology such as patch-clamp as well as gene-targeted lesions. 5) A Small Business Innovative Research for development of a new design for metered dose inhalers (MDIs), and testing of a propellant to replace the chlorofluorocarbon (CFC) propellants currently being phased out by the Federal Government due to their high ozone-depletion potential. MDIs are in widespread use because asthma is one of the most common and costly illnesses in the United States, and drug formulation delivered via MDIs represent the primary treatment method for asthma sufferes. With the phase-out of CFCs, there is a need for a replacement that is safe, effective, and economical.
CRITERIA FOR SELECTING PROPOSALS:
The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the scientific, technical, or technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the qualifications of the proposed principal investigator, supporting staff, and consultants; (4) the technological innovation, originality, or societal importance of the proposed research; (5) the potential of the proposed research for commercial application; (6) the reasonableness of the budget requested for the work proposed; (7) the adequacy and suitability of the facilities and research environment; (8) The adequacy of plans to include both genders and minorities and their subgroups as appropriate for the scientific goals of the research. Plans for the recruitment and retention of subjects will be evaluated; and (9) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment.